SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announces the appointment of Craig Johnson as Chief Financial Officer, effective August 1, 2011. Mr. Johnson has more than 15 years’ experience as a senior financial executive in the healthcare industry.
